Fidia worldwide

Fidia Pharma USA Inc.

Fidia Pharma USA Inc is a wholly-owned subsidiary of Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., focused on continually expanding Fidia's position in the U.S. market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance.

Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as musculoskeletal, rheumatology, and women's health.

Learn more about the Company, visit www.fidiapharma.us

Fidia Pharma GmbH

Fourth in the Group, in addition to Italian headquarters and the US and Kazak subsidiaries, Fidia Pharma GmbH represents an additional step in the company's internationalization plan, a higher penetration of Fidia's products in the European market and a more direct, stronger contribution to the spreading and widening of Italian research and industrial excellence worldwide

Fidia Pharma GmbH will initially focus on the viscosupplementation for synovial joints and wound care areas, through products containing hyaluronic acid.

Learn more about the Company, visit www.fidiapharma.de

Laboratorios Fidia Farmacéutica S.L.U

Laboratorios Fidia Farmacéutica S.L.U. falls within the international expansion and growth strategies of the group, through direct investments in the Spanish market

After initially focusing on the viscosupplementation for synovial joints through products containing hyaluronic acid, Laboratorios Fidia Farmacéutica S.L.U is consolidating its know-how and global presence in the field of regenerative medicine, specifically in joint care and aesthetic medicine.

Learn more about the Company, visit www.fidiapharma.es

Fidia Pharma Middle East F.Z.E.

Drawing on the strengths of the parent company, Fidia Pharma Middle East F.Z.E. is focused on providing healthcare professionals and consumers with innovative products, for the treatment of commonly occurring pathologies with serious social and economic impact.

Fidia Pharma Middle East F.Z.E. will initially focus on the viscosupplementation for synovial joints and wound care areas, through products containing hyaluronic acid.

Learn more about the Company, visit www.fidiapharma.ae
 

Wholly-owned subsidiaries

Therapeutic areas include Joint healthcare, advanced wound care and women's health

Direct access to strategic markets

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- ophthalmology
- wound care
- dermatology
- neurology
- dermo-aesthetics